Baxter Clearlink Intravenous (IV) Delivery System recallZ-0193-05 · Baxter Healthcare Corp. · initiated Apr 28, 2004
Terminated All recalls posted in November 2004
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Baxter Healthcare Corp. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Inadequate directions for use may have contributed to an increase in infection rates at a small number of customers beginning use of the Clearlink needleless device.
FDA root cause category: Other
What the company is doing
An Urgent Device Correction letter and reply form dated 4/28/04 were sent to all U.S. Clearlink customers, informing them of the reports of increased infection rates abd describing the revision of the product labeling with additional statements that relate to product usage and reinforcement of standard clinical practices and proper aseptic technique. The revised labeling statements are as follows: * Ensure clamp is open. Swab Luer activated surface with preferred antiseptic prior to first use and before every subsequent connection. * Don not swab Luer activated surface when clamp is closed or valve is recessed. Ineffective swabbibg may result. Replace if valve remains recessed. * Flush Luer activated valve after blood infusion/sampling. If valve cannot be cleared of blood, replace immediately. * Luer lock vacutainer holders, syringes and accessories are recommended for blood sampling. If blood remains on valve surface after sampling, swab surface. * If intermittently disconnecting set from Luer activated valve, immediately cover male Luer with a sterile replacement protector.
Recall details
- Recall number
- Z-0193-05
- Recall class
- Not yet classified by the FDA
- Status
- Terminated
- Initiated by the company
- Apr 28, 2004
- Posted by the FDA
- Nov 16, 2004
- Recalling firm
- Baxter Healthcare Corp.
- Quantity
- 29,425,708 sets
- Product code
- FPA
- FDA submissions
- K832284, K981792, K984381, K993120, K003225
- Distribution
- Nationwide, and internationally through Baxter subsidiaries to Macedonia, Nigeria, Saudi Arabia, South Africa, Ireland, Italy, Denmark, Germany, the Netherlands, Hong Kong, Indonesia, Singapore, Spain, Belgium, Norway, United Kingdom, France and Luxembourg.
Product description
Baxter Clearlink Intravenous (IV) Delivery System; the system consists of solution sets, extension sets and blood sets that have a luer activated valve for IV access, which allows the administration of medications/solutions with a needleless luer syringe; Baxter Healthcare Corporation, Deerfield, IL 60015 USA
Code information (models, lots, serial numbers)
Show the full code information (1k characters)
all lots of product code 2N8399, 1C8678, 1C8680, 1C8683, 1C8684, 1C8687, 1C8693, 1C8702, 1C8704, 1C8705, 1C8706, 1C8707, 1C8712, 1C8722, 1C8723, 1C8727, 2C0168, 2C6254, 2C6255, 2C6256, 2C7461, 2C7462, 2C8401, 2C8402, 2C8419, 2C8425, 2C8428, 2C8515, 2C8519, 2C8537, 2C8541, 2C8546, 2C8548, 2C8571, 2C8593, 2C8606, 2C8607, 2C8610, 2C8612, 2C8632, 2C8634, 2C8671, 2C8700, 2C8720, 2C8750, 2C8751, 2C8819, 2C8851, 2C8857, 2C8858, 2C8860, 2C8862, 2C8864, 2C8865, 2C8875, 2C8891, 2C8895, 2C8920, 2C8921, 2C8930, 2C8931, 2H7462, 2H7463, 2H8401, 2H8480, 2H8486, 2H8519, 2H8603, 2H8720, 2H8750, 2H8819, 2H8860, 2H8862, 2H8864, 2H8865, 2N8300, 2N8334, 2N8335, 2N8341, 2N8371, 2N8373, 2N8374, 2N8377, 2N8378, 2N9204K, 2N9205K, 3C0122, 3C0134, 3C0139, 3C0143, 3C0148, 3C0150, 3C0151, 3C0157, 3C0158, 3C0159, 3C0160, 3C0162, 3C0165, 4C8714, 4C8723, 4H8723
Other devices under the same FDA submission
15 devices cleared under K832284, K981792, K984381, K993120, K003225 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.
- CLEARLINK 2C8750Baxter Healthcare Corporation · Set, blood transfusion176 reports
- CLEARLINK 2C8858Baxter Healthcare Corporation · Set, administration, intravascular80 reports
- INTERLINK 2C7558Baxter Healthcare Corporation · Set, administration, intravascular30 reports
- CLEARLINK 4C8723Baxter Healthcare Corporation · Set, blood transfusion1 death30 reports
- CLEARLINK 2C8857Baxter Healthcare Corporation · Set, administration, intravascular18 reports
- INTERLINK 2C6750HBaxter Healthcare Corporation · Set, blood transfusion18 reports
- INTERLINK 2C7557Baxter Healthcare Corporation · Set, administration, intravascular10 reports
- INTERLINK 2C6700Baxter Healthcare Corporation · Set, blood transfusion8 reports
- Baxter 2C7627Baxter International Inc. · Set, blood transfusion7 reports
- INTERLINK 2C6723Baxter International Inc. · Set, blood transfusion5 reports
- CLEARLINK 2C8720Baxter Healthcare Corporation · Set, blood transfusion5 reports
- INTERLINK 2C6720Baxter International Inc. · Set, blood transfusion3 reports
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 18, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page